The telomerase challenge - An unusual problem in drug discovery

Anne E. Pitts, David R. Corey

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Telomerase is a ribonucleoprotein that is responsible for maintaining telomere length. The observation that telomerase activity is found in many types of tumors, but not in adjacent normal tissue, has led to the hypothesis that telomerase is a novel target for chemotherapy. Inhibitors of telomerase activity are essential to validate this hypothesis, and their design presents special opportunities and challenges.

Original languageEnglish (US)
Pages (from-to)155-161
Number of pages7
JournalDrug Discovery Today
Volume4
Issue number4
StatePublished - 1999

Fingerprint

Telomerase
Drug Discovery
Ribonucleoproteins
Telomere
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

The telomerase challenge - An unusual problem in drug discovery. / Pitts, Anne E.; Corey, David R.

In: Drug Discovery Today, Vol. 4, No. 4, 1999, p. 155-161.

Research output: Contribution to journalArticle

@article{a7bdb846d24942f5a252aacc1466b3f9,
title = "The telomerase challenge - An unusual problem in drug discovery",
abstract = "Telomerase is a ribonucleoprotein that is responsible for maintaining telomere length. The observation that telomerase activity is found in many types of tumors, but not in adjacent normal tissue, has led to the hypothesis that telomerase is a novel target for chemotherapy. Inhibitors of telomerase activity are essential to validate this hypothesis, and their design presents special opportunities and challenges.",
author = "Pitts, {Anne E.} and Corey, {David R.}",
year = "1999",
language = "English (US)",
volume = "4",
pages = "155--161",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - The telomerase challenge - An unusual problem in drug discovery

AU - Pitts, Anne E.

AU - Corey, David R.

PY - 1999

Y1 - 1999

N2 - Telomerase is a ribonucleoprotein that is responsible for maintaining telomere length. The observation that telomerase activity is found in many types of tumors, but not in adjacent normal tissue, has led to the hypothesis that telomerase is a novel target for chemotherapy. Inhibitors of telomerase activity are essential to validate this hypothesis, and their design presents special opportunities and challenges.

AB - Telomerase is a ribonucleoprotein that is responsible for maintaining telomere length. The observation that telomerase activity is found in many types of tumors, but not in adjacent normal tissue, has led to the hypothesis that telomerase is a novel target for chemotherapy. Inhibitors of telomerase activity are essential to validate this hypothesis, and their design presents special opportunities and challenges.

UR - http://www.scopus.com/inward/record.url?scp=0000217902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0000217902&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0000217902

VL - 4

SP - 155

EP - 161

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 4

ER -